Massachusetts Financial Services’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$461K	Sell	59,770 -1,587	-3%	-$11.6K	﹤0.01%	898
2025 Q4	$376K	Sell	61,357 -2,029	-3%	-$21.9K	﹤0.01%	887
2025 Q3	$1.17M	Buy	63,386 +4,169	+7%	+$67K	﹤0.01%	795
2025 Q2	$770K	Buy	59,217 +731	+1%	+$8.64K	﹤0.01%	834
2025 Q1	$619K	Sell	58,486 -1,331	-2%	-$21.1K	﹤0.01%	835
2024 Q4	$1.02M	Buy	59,817 +10,860	+22%	+$204K	﹤0.01%	819
2024 Q3	$1.14M	Buy	48,957 +10,728	+28%	+$229K	﹤0.01%	790
2024 Q2	$931K	Sell	38,229 -2,897	-7%	-$87.9K	﹤0.01%	803
2024 Q1	$1.39M	Sell	41,126 -91	-0.2%	-$3.22K	﹤0.01%	759
2023 Q4	$1.3M	Buy	41,217 +3,457	+9%	+$82.2K	﹤0.01%	755
2023 Q3	$965K	Sell	37,760 -1,447	-4%	-$44.6K	﹤0.01%	765
2023 Q2	$1.12M	Buy	+39,207	New	+$1.07M	﹤0.01%	745
2021 Q2	–	Sell	-8,483	Closed	-$350K	–	908
2021 Q1	$350K	Sell	8,483 -4,945	-37%	-$295K	﹤0.01%	895
2020 Q4	$583K	Sell	13,428 -135	-1%	-$9.14K	﹤0.01%	833
2020 Q3	$582K	Buy	+13,563	New	+$673K	﹤0.01%	817